Skip to Main Content

Paper Details

Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci.
Oncotarget
6
2017
19p12, 1q22, 1q22 and 19p12 loci, 1q22 and 19p12 outcome loci, MEF2D, MEF2D promoter, ZNF100, ZNF100 promoter region, candidate outcome variants, epithelial ovarian cancer, genetic loci, germline, ovarian cancer, ovarian outcome loci, patient, patients, target
Author NameAffiliation
Sharon E JohnattyQIMR Berghofer Medical Research Institute
Jonathan TyrerUniversity of Cambridge
Bo GaoWestmead Hospital
Bo GaoCenter for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney
Peter A FaschingUniversity of California at Los Angeles, David Geffen School of Medicine
Peter A FaschingUniversity Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN
Diether LambrechtsVesalius Research Center
Diether LambrechtsUniversity of Leuven
Digna R Velez EdwardsVanderbilt Genetics Institute, Vanderbilt University School of Medicine
Alicia Beeghly-FadielVanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Javier Ben??tezSpanish National Cancer Centre (CNIO)
Mar??a J Garc??aSpanish National Cancer Centre (CNIO)
Marc T GoodmanSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Marc T GoodmanCommunity and Population Health Research Institute, Cedars-Sinai Medical Center
Pamela J ThompsonSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Pamela J ThompsonCommunity and Population Health Research Institute, Cedars-Sinai Medical Center
Andreas du Bois
Andreas du Bois
Jacobus Pfisterer
Beth Y KarlanWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Jenny LesterWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Ellen L GoodeMayo Clinic
Stacey J WinhamMayo Clinic
Melissa C LarsonMayo Clinic
Bryan M McCauleyMayo Clinic
Joellen M SchildkrautThe University of Virginia
Andrew BerchuckDuke University Medical Center
Tanja PejovicOregon Health & Science University
Tanja PejovicKnight Cancer Institute, Oregon Health & Science University
Rosalind GlasspoolBeatson West of Scotland Cancer Centre
David G HuntsmanVancouver General Hospital, BC Cancer Agency and University of British Columbia
David G HuntsmanThe University of British Columbia
David G HuntsmanVancouver General Hospital, BC Cancer Agency and University of British Columbia
David G HuntsmanThe University of British Columbia
Aocs GroupQIMR Berghofer Medical Research Institute
Aocs GroupPeter MacCallum Cancer Center, The University of Melbourne
Anna DeFazioCenter for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney
Anna DeFazioWestmead Hospital
Anna DeFazioCenter for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney
Anna DeFazioWestmead Hospital
Catherine J KennedyCenter for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney
Catherine J KennedyWestmead Hospital
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
  • 1 - 48

Datasets